• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

SNP Genotyping and Analysis Markets

$1,995.00 – $7,990.00

Clear
SKU: KLI1430117 Categories: Biotechnology Market Research, Emerging Technologies Market Reports Pages: 201
  • Description
  • Table of Contents
  • Latest reports

Description

SNPs (single nucleotide polymorphisms), single base pair mutations that occur at a specific site in the DNA sequence, are the most common type of genetic variation between human beings. Because they are responsible for over 80% of the variation between two individuals, SNPs are ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism.

The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and market watchers in diagnostics, pharmaceutical, biotechnology and related instrument industries will want to watch developments in SNP analysis closely.

Kalorama Information’s analyst Justin Saeks has taken a detailed look into the market for DNA Sequencing Equipment, as well as Gene Expression Profiling Systems. Now, in His report SNP Genotyping and Analysis Markets he looks at SNPs analysis instruments, reagents, software and services, providing information critical to having an understanding of the business behind this new technology:

  • Overview of SNPs, their Applications and Key SNP Analysis Methods
  • Current Market Size and Estimates of Future Growth
  • Estimates of Revenues by Region (North America, Europe and ROW) and By Product Type (Consumable, Instruments, Software)
  • Complete List of Over 180 SNP-Related Deals Made Between Companies Since 2002
  • Exhaustive Review of Products on the Market
  • Market Share of Major Companies in SNP Analysis
  • Discussion of Government Involvement and Funding
  • Corporate Profiles
  • Regulatory, Technology and Industry Trends
    as well as;
  • Eight Strategic Recommendations for Companies in the SNP Analysis Market

While the market is expected to create opportunities for growth, the SNP Genotyping and Analysis market is not without its challenges. The following will impact the market:

 

  • Cheaper Sequencing Creates Competition
  • Small Number of Suppliers
  • Issues With Use of Public Databases
  • Data Management Requirements
  • Backlash Against Rush Into Genetic Testing, DTC Marketing
  • Standard Processes for SNP Experiments Still Not Established
  • Shortcomings in Sample Preparation and Handling Hinder Success
  • Privacy Concerns Pose Threat to Broad Technology Adoption

 

 

As with all Kalorama Information publications, SNP Genotyping and Analysis Markets is the result of a primary research effort. An analyst with experience following the biotech instrument industry researching all available sources and contacting industry experts and end users to obtain real market insights. Strategic Planners, Marketing Directors, Business Development Executives are among the individuals who will benefit from this resource.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • What is a SNP?
  • Applications
  • The Market
  • Competitive Analysis
  • Challenges
  • Scope and Methodology

CHAPTER TWO: INTRODUCTION

  • Background
  • SNP Analysis Methods
    • Amplification
    • Allele discrimination / assay reaction mechanism
    • Single Nucleotide Addition; Pyrosequencing
    • Assay Format
    • Detection Method
  • Scope and Methodology
  • Definitions
    • DNA Microarray
    • Genome-Wide Association
    • Linkage Analysis
    • Mass Spectrometry
    • Single-Nucleotide Polymorphism (SNP)

CHAPTER THREE: APPLICATIONS

  • Life Science Research
  • Pharmacogenetics / Pharmacogenomics
    • Case Study #1 — SNPs in Gene for P-glycoprotein Affect Antidepressant Response
    • Case Study #2 – Celera Studying SNPs Associated With Heart Disease
    • Case Study #3 – Synonymous SNPs Alter mRNA Splicing with Obesity
    • Case Study #4 – University of Ottawa Heart Institute (UOHI) Coronary Artery
    • Disease Research

CHAPTER FOUR: INDUSTRY AND REGULATORY TRENDS

  • Industry Trends
    • Consolidation Occurring in Array and Life Science Markets
    • FDA Involvement Making Drug Industry More Comfortable
    • Acceptance of SNP Analysis, Pharmacogenetics Reached Tipping Point
    • Core Labs Becoming Established Paradigm
  • Technology Trends
    • Increased Multiplexing Expands Applications
    • End-Users Attracted to Larger-Scale SNP Platforms
    • Complexity of Biological Systems Requires Multiple Techniques
    • Miniaturization of Equipment and Instruments
  • Regulatory Trends
    • Introduction
    • Critical Path Initiative
    • March 2005 – “Guidance for Industry – Pharmacogenomic Data Submissions”
    • April 2005 – “Drug-Diagnostic Co-Development Concept Paper”
    • March 2006 – Critical Path Opportunities List
    • November 2006 – “Recommendations for the Generation and Submission of
    • Genomic Data”
    • August 2007 – “Pharmacogenomic Data Submissions — Companion Guidance”
    • August 2007 – FDA Updates Labeling of Warfarin (Coumadin)
    • December 2007 – EGAPP Reviews Use of CYP450 Genetic Testing For SSRIs

CHAPTER FIVE: PRODUCTS

  • Affymetrix
    • Overview of Affymetrix Products
    • Hardware
  • Applied Biosystems
    • Overview of Applied Biosystems Products
    • Assays and Reagent
    • Instruments
  • Beckman Coulter
  • CombiMatrix
  • febit
  • GE Healthcare
  • Illumina
  • Hardware
  • Microarrays
  • LI-COR Biosciences (Lincoln, NE)
  • Roche Applied Science
  • Sequenom
  • Services
  • Agencourt Biosciences
  • DNAPrint Genomics
  • Polymorphic DNA Technologies
  • Software
  • Applied Biosystems
  • Premier Biosoft
  • Public Tools

CHAPTER SIX: CONSORTIA, GOVERNMENT INVOLVEMENT, DEALS

  • Consortia, Collaborative Projects
  • The Cancer Genome Atlas (TCGA) Pilot Project
  • Cancer Sequencing Project
  • Critical Path Institute
  • DNA Polymorphism Discovery Resource
  • Genetic Association Information Network (GAIN)
  • Genotype-To-Phenotype Database (GEN2PHEN)
  • International HapMap Project
  • Introduction & Background
  • Rationale for HapMap Approach
  • Process for Producing HapMap
  • Populations Included in HapMap
  • Measures Taken to Protect Donors’ Privacy
  • Laboratories and Technologies Involved in HapMap
  • Practical Use of the HapMap Data
  • MicroArray Quality Control (MAQC) Project
  • NIH Roadmap
  • NIH Roadmap for Medical Research
  • Pharmacogenetics Research Network (PGRN)
  • NIH Involvement, Funding for SNPs and Sequencing
  • Funding for Sequencing Projects Affecting SNP Market
  • Continued Rapid Growth in Sequence Production
  • Funding and Consortia for Sequencing
  • NHGRI Funds Large-Scale Sequencing Centers, 2006
  • Competitive Activity

CHAPTER SEVEN: MARKET DATA AND COMPETITIVE ANALYSIS

  • Historical
  • Illumina as Bellwether for SNP Analysis Market
  • Applied Biosystems as Bellwether for RT-PCR Products
  • Forecast
  • Assumptions
  • SNP Revenues by Region
  • SNP Revenues by Product
  • Competitive Analysis

CHAPTER EIGHT: CORPORATE PROFILES

  • Affymetrix
  • Applied Biosystems
  • Illumina

CHAPTER NINE: CHALLENGES AND STRATEGIC RECOMMENDATIONS

  • Challenges
  • Cheaper Sequencing Creates Competition for SNP Analysis Platforms
  • Market Is Dominated by a Small Number of Suppliers
  • Issues Arise With Use of Public Databases
  • Data Management Requirements Limit Large-Scale Technologies
  • Diagnostic Market Holds Obstacles For New Innovations
  • Backlash Against Rush Into Genetic Testing, DTC Marketing
  • Standard Processes for SNP Experiments Still Not Established
  • Shortcomings in Sample Preparation and Handling Hinder Success
  • Privacy Concerns Pose Threat to Broad Technology Adoption
  • Strategic Recommendations

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure-1-1: SNP Analysis Market 2007-2013
  • Figure 1-2: Growth Rate in SNP Analysis Revenues 2008-2013

CHAPTER TWO: INTRODUCTION

  • Table 2-1 Adelle-Specific Invasive Cleavage
  • Table 2-2 Adelle-Specific Ligation
  • Table 2-1 Allele-Specific Primer Extension
  • Table 2-4 Single Base Primer Extension

CHAPTER FOUR: INDUSTRY AND REGULATORY TRENDS

  • Table 4-1: Critical Path Opportunities List

CHAPTER FIVE: PRODUCTS

  • Figure 5-1: Taq Man Assay
  • Figure 5-2: SOLID System Average Throughput Progress
  • Figure 5-3: SNPstream Method
  • Figure 5-4: Roche SimpleProbe System
  • Figure 5-5: Roche HybProbe System
  • Table 5-1 Products in the SNP Analysis Market
  • Table 5-2 Public SNP Tools and Resources (Tool, Website)

CHAPTER SIX: CONSORTIA, GOVERNMENT INVOLVEMENT, DEALS

  • Figure 6-1: Domains of Genomes Sequenced by Year (Archaea, Bacteria, Eukaryota)
  • Major Sequencing Centers, Jan 2008
  • Figure 6-5: Top Funding Agencies, DNA Sequencing, 2008
  • Figure 6-4: Major Sequencing Centers and Percent of Sequencing Projects (WORLD, GENOSCOPE, BMC, Sanger, WashU, BROAD, JCVI, JGI), Jan 2008
  • Figure 6-5: Top Funding Agencies, DNA Sequencing, 2008 ($M)
  • Figure 6-6: Human Genome Project Funding, DOE& NIH ’90-‘03
  • Figure 6-7: Areas Funding Genome Sequencing, Jan 2008 (Medical, Evolutionary, Agricultural, Environmental, Biotechnology)
  • Table 6-5: Large-Scale Sequencing Centers, NHGRI Funding, 2004-2006
  • Figure 6-8: Top Genome Sequencing Countries, Jan. 2008 (# projects)
  • Figure 6-9: SNP Analysis Related Deals (Companies, Date, Details of Deal)
  • Figure 6-10: SNP: NHGRI Funded Large-Scale Sequencing Ctrs, ‘07
  • Table 6-6: SNP Analysis-Related Deals (Companies, Date, Details of Deal)

CHAPTER SEVEN: MARKET DATA AND COMPETITIVE ANALYSIS

  • Figure 7-1: Illumina Quarterly Revenues, 2001-2007 ($M)
  • Figure 7-2: Applied Biosystems Revenues in Real Time PCR/Applied Genomics
  • Table-7-1: Forecasted Revenues in the SNP Analysis Market
  • Figure-7-3: Forecasted Revenues in the SNP Analysis Market
  • Table 7-2: Growth Rate in SNP Analysis Tools Market, 2008-2013
  • Figure 7-4: Growth Rate in SNP Analysis Tools Market, 2008-2013
  • Figure 7-5: SNP Analysis Revenues by Region (North America, Europe, Rest of World)
  • Table 7-3: SNP Analysis Revenues by Region (North America, Europe, Rest of World)
  • Figure 7-6 SNP Market by Product Segment (Instruments, Consumables, Software & Services)
  • Table 7-4: SNP Market by Segment (Instruments, Consumables, Software & Services)
  • Table 7-5: Revenues Among the Top Companies in SNP Analysis (Illumina, Affymetrix, Applied Biosystems, Other)
  • Figure 7-7: SNP Analysis Market Share, 2007

CHAPTER EIGHT: CORPORATE PROFILES

  • Figure 8-1: Affymetrix’ Revenues by Product Type, 2004 – 2007
  • Figure 8-2: Illumina BeadStation Installed Base, 2004-2006

CHAPTER NINE: CHALLENGES AND STRATEGIC RECOMMENDATIONS

  • Figure 9-1: Estimated Decrease in Screening Price

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Orthopedic Biomaterials, The World Market, 2nd Edition

    $1,995.00 – $7,000.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition

    $995.00 – $1,990.00
  • Placeholder image

    Biomarkers – A Market Briefing

    $995.00 – $3,990.00
  • Placeholder image

    Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edit...Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )
Scroll to top